EBS Reports That Its NEXT WAVE™ Brain Stimulation Device Has Been Used Successfully to Treat the First Patient at Charité, One of the Largest University Hospitals in Europe

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BERLIN--(BUSINESS WIRE)--EBS Technologies (“EBS”) announced today that Charité Berlin, one of the largest university hospitals in Europe, has successfully treated its first patient with the EBS NEXT WAVE™ brain stimulation device designed to expand the visual field of patients with impaired vision, e.g. caused by optic nerve damage.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC